Table 2.
Analysis of cell types via marker genes
| System | Cell type | Marker | Acute | Chronic | ||||
|---|---|---|---|---|---|---|---|---|
| Greater | log2FC | Q | Greater | log2FC | Q | |||
| Innate immune system | Dendritic cell | CD83 | 0.14 | 0.77 | −0.02 | 0.98 | ||
| Macrophage | CD68 | 0.66 | 0.12 | 0.47 | 0.07 | |||
| M1 macrophage | CD86 | 0.50 | 0.16 | −0.18 | 0.68 | |||
| M2 macrophage | CMAF | 0.46 | 0.12 | 0.32 | 0.18 | |||
| Mast cell | KIT | −0.05 | 0.95 | AN | 0.57 | 0.01 | ||
| Granulocyte | Ly6C | 0.19 | 0.91 | 0.26 | 0.87 | |||
| NK cell | KLRA1 | 0.63 | 0.15 | AN | 1.20 | <0.01 | ||
| Adaptive immune system | T cell | CD3g | SD | −2.37 | 0.02 | −0.88 | 0.17 | |
| Helper T cell | CD4 | SD | −1.20 | <0.01 | −0.25 | 0.36 | ||
| Th1 cell | CCR5 | −0.12 | 0.83 | −0.14 | 0.72 | |||
| Th2 cell | CXCR4 | AN | 0.65 | 0.02 | AN | 0.49 | 0.01 | |
| Cytotoxic T cell | CD8a | AN | 1.39 | <0.01 | −0.37 | 0.16 | ||
| B cell | CD19 | −1.29 | 1.00 | 0.74 | 1.00 | |||
| Central nervous system | Neuron | NEFH | −3.31 | 0.05 | SD | −1.90 | <0.01 | |
| Oligodendrocyte | PLP | −1.27 | 0.30 | −0.21 | 0.82 | |||
| Astrocyte | GFAP | −1.48 | 0.34 | 0.00 | 1.00 | |||
FC fold change (AN FKPM divided by SD FKPM); Q, false discovery rate-adjusted P value